UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043105
Receipt number R000043410
Scientific Title Comparison of intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy
Date of disclosure of the study information 2021/01/23
Last modified on 2021/01/23 02:47:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy

Acronym

Comparison of intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy

Scientific Title

Comparison of intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy

Scientific Title:Acronym

Comparison of intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy

Region

Asia(except Japan)


Condition

Condition

Intrathecal midazolam and fentanyl added to bupivacaine for spinal anesthesia in patients undergoing appendicectomy

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare intrathecal fentanyl and midazolam in combination with hyperbaric bupivacaine, for the duration and quality of sensory and motor blockade after spinal anesthesia in patients undergoing appendicectomy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Intrathecal midazolam and fentanyl added to bupivacaine in patients undergoing appendicectomy reduces intraoperative pain and increases duration of post-operative analgesia.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Group BM: Intrathecal 3ml of 0.5% hyperbaric Bupivacaine with 0.4ml (2mg) midazolam

Interventions/Control_2

Group BF: Intrathecal 3ml 0.5% hyperbaric Bupivacaine with 0.4mls (20micrograms) Fentanyl

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

1) Scheduled for elective or emergency appendicectomy requiring sub arachnoid block.
2) All patients of ASA physical status I-II.
3) Age group of 15-70 yrs of age.

Key exclusion criteria

1) Patient refusal.
2) Infection at the site of injection.
3) Deformities of spinal column.
4) Mental disturbance or neurological disease.
5) Known case of allergic to drugs used.

Target sample size

44


Research contact person

Name of lead principal investigator

1st name Puja
Middle name
Last name Thapa

Organization

Nepal Army Institute of Health Sciences

Division name

Bagmati

Zip code

44600

Address

Chhauni,Kathmandu

TEL

+9779851152449

Email

thapa_puza@yahoo.com


Public contact

Name of contact person

1st name Puja
Middle name
Last name Thapa

Organization

Nepalese Army Institute of Health Sciences

Division name

Bagmati

Zip code

44600

Address

Chhauni, Kathmandu

TEL

+9779851152449

Homepage URL

http://naihs.edu.np/

Email

thapa_puza@yahoo.com


Sponsor or person

Institute

Shree Birendra Hospital

Institute

Department

Personal name



Funding Source

Organization

Nepal Army Institute of Health Sciences

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nepalese Army Institute of Health Sciences

Address

Sanobharyang, kathmandu

Tel

+977-1-4881259

Email

info@naihs.edu.np


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 23 Day


Related information

URL releasing protocol

https://www.nepjol.info/index.php/nmj/authorDashboard/submission/34398

Publication of results

Unpublished


Result

URL related to results and publications

https://www.nepjol.info/index.php/nmj/authorDashboard/submission/34398

Number of participants that the trial has enrolled

50

Results

Total 44 patients were studied with 22 in each arm. The two groups were comparable in terms of age, weight, height, duration of surgery and ASA status of the patients. Peak sensory level and degree of motor block were not statistically different in two arms. Duration of effective analgesia was 293.16 min in BF group and 267.80 min in BM group. Increased incidence of pruritus was recorded during the postoperative period in Fentanyl group.

Results date posted

2021 Year 01 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

They were similar in baseline characteristics

Participant flow

Out of the 50 cases, 44 patients were enrolled in the study with 22 in each arm.

Adverse events

None except minor cases of pruritus

Outcome measures

There was no statistical difference in peak sensory level, degree of motor block and quality of intraoperative analgesia between two groups

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 14 Day

Date of IRB

2018 Year 06 Month 24 Day

Anticipated trial start date

2018 Year 07 Month 01 Day

Last follow-up date

2018 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 23 Day

Last modified on

2021 Year 01 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043410


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name